US 9650447
Complement receptor 2 (CR2) targeting groups
granted A61PA61P1/04A61P11/06
Quick answer
US patent 9650447 (Complement receptor 2 (CR2) targeting groups) held by The Regents of the University of Colorado, a Body Corporate expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P1/04, A61P11/06, A61P11/16, A61P13/12